‘Overwhelming Efficacy’ Found in New Lung Cancer Drug – Yale PhD Calls it ‘Transformative’

Article Link: https://www.goodnewsnetwork.org/overwhelming-efficacy-found-in-new-lung-cancer-drug-yale-phd-calls-it-transformative/

Discussion posted by: David McNamara

Clinical trials of a new lung cancer treatment has showed unprecedented results in decreasing the risk of death or recurrence from the disease by 89%. After embarking on phase three trials, the drug Tagrisso’s early results yielded such “overwhelming efficacy” that the independent committee monitoring the trial data has ruled the trial can become unblinded, meaning that both patient and administrator know who has received the drug and who has received placebo. At two years, 89% of all patients in the trial treated with Tagrisso, also called osimertinib, remained alive and disease free versus 53% on placebo.